Vaneck Vectors Pharmaceutical etf shares owned by Raleigh Capital Management
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Raleigh Capital Management
from 13F filings
Historical chart of Raleigh Capital Management investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Raleigh Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Raleigh Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $21k | 257 | 81.36 |
| 2023-09-30 | $0 | 0 | 0.00 |
| 2023-06-30 | $20k | 258 | 78.81 |
| 2023-03-31 | $20k | 256 | 77.63 |
| 2022-12-31 | $20k | 256 | 77.73 |
| 2022-09-30 | $17k | 254 | 66.93 |
| 2022-06-30 | $19k | 253 | 75.10 |
| 2022-03-31 | $20k | 252 | 79.37 |
More positions owned by Raleigh Capital Management
View all positions for Raleigh Capital Management
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf